| 2.5 |
10.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.9 |
5.7 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.6 |
4.8 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 1.6 |
8.0 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 1.4 |
7.0 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.3 |
5.4 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.3 |
4.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.3 |
9.1 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.3 |
16.6 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.9 |
3.8 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.9 |
2.6 |
GO:0046959 |
habituation(GO:0046959) |
| 0.8 |
2.5 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.8 |
4.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.8 |
3.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.8 |
5.3 |
GO:0032811 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of epinephrine secretion(GO:0032811) |
| 0.8 |
3.8 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.7 |
4.4 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.7 |
14.1 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.7 |
2.8 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 0.7 |
2.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.6 |
5.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
2.5 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.6 |
6.3 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 |
1.9 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.6 |
3.1 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.6 |
3.0 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.6 |
1.8 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.6 |
3.0 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
1.6 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.5 |
2.2 |
GO:0000820 |
regulation of glutamine family amino acid metabolic process(GO:0000820) |
| 0.5 |
2.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.5 |
3.6 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.5 |
2.6 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.5 |
2.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.5 |
2.9 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 |
2.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.5 |
1.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.5 |
1.4 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.5 |
1.8 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.5 |
1.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.5 |
1.8 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 |
1.4 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
1.3 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.4 |
4.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.4 |
2.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.4 |
2.0 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.4 |
4.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.4 |
0.4 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.4 |
1.8 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.4 |
1.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
2.5 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
3.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 |
1.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.3 |
1.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
0.3 |
GO:0002488 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.3 |
1.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
4.4 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.3 |
1.2 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
1.5 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
1.2 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 |
1.2 |
GO:1904996 |
diapedesis(GO:0050904) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 |
1.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.3 |
1.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
1.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 |
1.9 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 |
2.1 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
6.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
2.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
1.2 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
1.0 |
GO:0010046 |
arginine biosynthetic process(GO:0006526) response to mycotoxin(GO:0010046) |
| 0.2 |
1.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
1.7 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.2 |
0.9 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
6.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
0.9 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.2 |
1.4 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
1.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 |
2.3 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 |
0.9 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
0.9 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
1.3 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.2 |
0.8 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.2 |
1.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
1.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
5.2 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 |
2.9 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 |
0.6 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 |
0.7 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
1.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.7 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.2 |
2.7 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 |
1.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
1.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
1.5 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 |
2.9 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.2 |
0.9 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 |
0.8 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
3.0 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
2.1 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.5 |
GO:0061324 |
cardiac right atrium morphogenesis(GO:0003213) mammary placode formation(GO:0060596) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 0.2 |
0.8 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 |
4.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
3.5 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
1.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.7 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.9 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
1.4 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
2.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.4 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
1.0 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 |
0.5 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.9 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
3.3 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
0.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
1.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.7 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.5 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.1 |
3.5 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
1.4 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
1.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.4 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 |
0.7 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
1.0 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.4 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
1.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
1.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
1.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
2.9 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
2.6 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.4 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
1.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.3 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.4 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.5 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.5 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
1.5 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
2.4 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
1.6 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.1 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.1 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.2 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
2.1 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.6 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
5.5 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.1 |
0.7 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
1.4 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 |
0.7 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.1 |
0.1 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.3 |
GO:0045986 |
negative regulation of smooth muscle contraction(GO:0045986) |
| 0.1 |
0.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.5 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.1 |
2.3 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
1.0 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.3 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.0 |
0.8 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
5.3 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.0 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.3 |
GO:1903025 |
regulation of histone H3-K36 methylation(GO:0000414) regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
1.0 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
1.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
2.4 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
1.3 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
1.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
1.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
1.1 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.0 |
0.6 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
1.5 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.5 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
1.5 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.7 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 |
0.2 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 |
0.6 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.9 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
1.9 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.0 |
0.5 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.5 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.3 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
1.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
1.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.9 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
1.0 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.7 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
1.7 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.0 |
1.7 |
GO:0006694 |
steroid biosynthetic process(GO:0006694) |
| 0.0 |
0.8 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
1.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
1.0 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
2.5 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.7 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
2.6 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.3 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.2 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
3.2 |
GO:0070588 |
calcium ion transmembrane transport(GO:0070588) |
| 0.0 |
2.0 |
GO:0017157 |
regulation of exocytosis(GO:0017157) |
| 0.0 |
0.5 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
2.8 |
GO:0006874 |
cellular calcium ion homeostasis(GO:0006874) |
| 0.0 |
0.7 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
1.0 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
1.5 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.5 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
1.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.1 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.4 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.0 |
0.5 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.7 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
0.2 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
